BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 15191043)

  • 21. Interstitial lung diseases: an observational study in patients admitted in "Marius Nasta" Institute of Pulmonology Bucharest, Romania, in 2011.
    Strâmbu I; Belaconi I; Stoicescu I; Ioniţă D; Cojocaru F; Niţă C; Dospinoiu D; Bumbăcea R
    Pneumologia; 2013; 62(4):206-11. PubMed ID: 24734353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Collagen 1a1 Expression by Airway Macrophages Increases In Fibrotic ILDs and Is Associated With FVC Decline and Increased Mortality.
    Tsitoura E; Trachalaki A; Vasarmidi E; Mastrodemou S; Margaritopoulos GA; Kokosi M; Fanidis D; Galaris A; Aidinis V; Renzoni E; Tzanakis N; Wells AU; Antoniou KM
    Front Immunol; 2021; 12():645548. PubMed ID: 34867934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum and bronchoalveolar lavage fluid levels of soluble B7H3 in patients with interstitial lung diseases.
    Nakashima T; Omori K; Namba M; Yamaguchi K; Sakamoto S; Horimasu Y; Masuda T; Miyamoto S; Iwamoto H; Fujitaka K; Hamada H; Hattori N
    Respir Med; 2023 Jun; 212():107224. PubMed ID: 37003499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Automated computer-based CT stratification as a predictor of outcome in hypersensitivity pneumonitis.
    Jacob J; Bartholmai BJ; Rajagopalan S; Karwoski R; Mak SM; Mok W; Della Casa G; Sugino K; Walsh SLF; Wells AU; Hansell DM
    Eur Radiol; 2017 Sep; 27(9):3635-3646. PubMed ID: 28130610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute exacerbations of fibrotic interstitial lung diseases.
    Suzuki A; Kondoh Y; Brown KK; Johkoh T; Kataoka K; Fukuoka J; Kimura T; Matsuda T; Yokoyama T; Fukihara J; Ando M; Tanaka T; Hashimoto N; Sakamoto K; Hasegawa Y
    Respirology; 2020 May; 25(5):525-534. PubMed ID: 31426125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proteolytic activities in bronchoalveolar lavage fluid of interstitial lung diseases: correlation to stage and prognosis.
    Schmidt M; Brugger E; Heinrich J
    Respiration; 1987; 52(2):115-21. PubMed ID: 3313577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A cluster-based analysis evaluating the impact of comorbidities in fibrotic interstitial lung disease.
    Wong AW; Lee TY; Johannson KA; Assayag D; Morisset J; Fell CD; Fisher JH; Shapera S; Gershon AS; Cox G; Halayko AJ; Hambly N; Manganas H; Sadatsafavi M; Wilcox PG; To T; Marcoux V; Khalil N; Kolb M; Ryerson CJ
    Respir Res; 2020 Dec; 21(1):322. PubMed ID: 33287805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bronchoalveolar lavage in chronic eosinophilic pneumonia. Analysis of six cases in comparison with other interstitial lung diseases.
    Pesci A; Bertorelli G; Manganelli P; Mori PA; Strinati F; Marangio E; Olivieri D
    Respiration; 1988; 54 Suppl 1():16-22. PubMed ID: 3231902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic hypersensitivity pneumonitis or idiopathic pulmonary fibrosis? Diagnostic role of high resolution Computed Tomography (HRCT).
    Zompatori M; Calabrò E; Chetta A; Chiari G; Marangio E; Olivieri D
    Radiol Med; 2003 Sep; 106(3):135-46. PubMed ID: 14612834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Mast cells in bronchoalveolar lavage fluid of patients with interstitial lung diseases].
    Schildge J; Klar B; Hardung-Backes M
    Pneumologie; 2003 Apr; 57(4):202-7. PubMed ID: 12690558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The performance of the GAP model in patients with rheumatoid arthritis associated interstitial lung disease.
    Morisset J; Vittinghoff E; Lee BY; Tonelli R; Hu X; Elicker BM; Ryu JH; Jones KD; Cerri S; Manfredi A; Sebastiani M; Gross AJ; Ley B; Wolters PJ; King TE; Kim DS; Collard HR; Lee JS
    Respir Med; 2017 Jun; 127():51-56. PubMed ID: 28502419
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The diagnostic value of the bronchoalveolar lavage in interstitial lung diseases.
    Efared B; Ebang-Atsame G; Rabiou S; Diarra AS; Tahiri L; Hammas N; Smahi M; Amara B; Benjelloun MC; Serraj M; Chbani L; El Fatemi H
    J Negat Results Biomed; 2017 Mar; 16(1):4. PubMed ID: 28245857
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integrin α E β 7 (CD103) expression in bronchoalveolar lymphocytes of patients with hypersensitivity pneumonitis.
    Couto M; Palmares C; Beltrão M; Neves S; Mota P; Morais A; Delgado L
    Int Arch Occup Environ Health; 2015 Feb; 88(2):167-73. PubMed ID: 24874839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BAL cytokine profile in different interstitial lung diseases: a focus on systemic sclerosis.
    Meloni F; Caporali R; Marone Bianco A; Paschetto E; Morosini M; Fietta AM; Patrizio V; Bobbio-Pallavicini F; Pozzi E; Montecucco C
    Sarcoidosis Vasc Diffuse Lung Dis; 2004 Jun; 21(2):111-8. PubMed ID: 15281432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bronchoalveolar lavage fluid angiotensin-converting enzyme in interstitial lung diseases.
    Specks U; Martin WJ; Rohrbach MS
    Am Rev Respir Dis; 1990 Jan; 141(1):117-23. PubMed ID: 2153351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical evaluation of lymphocyte sub-populations and oxygen radical production in sarcoidosis and idiopathic pulmonary fibrosis.
    Groen H; Hamstra M; Aalbers R; van der Mark TW; Koëter GH; Postma DS
    Respir Med; 1994 Jan; 88(1):55-64. PubMed ID: 8029515
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pertechnegas lung clearance in different forms of interstitial lung disease.
    Thomeer MJ; Dehaes B; Mortelmans L; Demedts M
    Eur Respir J; 2002 Jan; 19(1):31-6. PubMed ID: 11843324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytological analysis of bronchoalveolar lavage in patients with interstitial lung diseases and the relation of cytological analysis to fibrosis in high-resolution computed tomography.
    Espoladore LM; Gregório BB; Lima MS; de Pereira CA; Soares MR; Coletta EN
    Anal Quant Cytopathol Histpathol; 2014 Aug; 36(4):206-12. PubMed ID: 25291858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Can exhaled nitric oxide differentiate causes of pulmonary fibrosis?
    Guilleminault L; Saint-Hilaire A; Favelle O; Caille A; Boissinot E; Henriet AC; Diot P; Marchand-Adam S
    Respir Med; 2013 Nov; 107(11):1789-96. PubMed ID: 24011803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predicting survival across chronic interstitial lung disease: the ILD-GAP model.
    Ryerson CJ; Vittinghoff E; Ley B; Lee JS; Mooney JJ; Jones KD; Elicker BM; Wolters PJ; Koth LL; King TE; Collard HR
    Chest; 2014 Apr; 145(4):723-728. PubMed ID: 24114524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.